June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Mitochondrial Complex I Dysfunction in Rods Does Not Impair Light Signaling
Author Affiliations & Notes
  • Sidney Gospe, III
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Alexander M. Warwick
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Mikael Klingeborn
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    McLaughlin Research Institute of Biomedical Sciences, Great Falls, Montana, United States
  • Amanda Travis
    University of Michigan, Ann Arbor, Michigan, United States
  • Lin Yu
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Sidney Gospe, III None; Alexander Warwick None; Mikael Klingeborn None; Amanda Travis None; Lin Yu None
  • Footnotes
    Support  RPB Career Development Award; NH Grant EY028610
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3217. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sidney Gospe, III, Alexander M. Warwick, Mikael Klingeborn, Amanda Travis, Lin Yu; Mitochondrial Complex I Dysfunction in Rods Does Not Impair Light Signaling. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3217.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The importance of oxidative metabolism in meeting photoreceptor energy needs remains controversial. We previously demonstrated that knockout mice lacking NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4), an accessory subunit of mitochondrial complex I, exhibited ~50% reduction of electroretinogram (ERG) a- and b-wave amplitudes in vivo, yet light responses were normal in ex vivo ERGs performed on isolated ndufs4-/- retinas. We hypothesize that the impaired in vivo light signaling was due to complex I dysfunction within retinal pigment epithelium (RPE) cells rather than photoreceptors.

Methods : To achieve cell-specific deletion of ndufs4 in rods and RPE, mice with floxed ndufs4 were crossed with iCre75 and Rpe65CreERT2 mice, respectively. Mice with Rpe65CreERT2 required tamixofen induction at postnatal day 30 (P30). ERG recordings were performed on dark-adapted iCre75;ndufs4loxP/loxP and Rpe65CreERT2;ndufs4loxP/loxPmice and littermate controls (n≧5 per genotype) at several time points. Depletion of NDUFS4 protein within ocular tissues was assessed via Western blot. Photoreceptor survival was assessed by outer retinal nuclei counts in retinal cross sections. Statistical comparisons between cohorts were made using two-tailed t tests.

Results : NDUFS4 protein content was depleted by >99% in the photoreceptors of iCre75;ndufs4loxP/loxP mice by P60. ERG recordings at P90 showed indistinguishable scotopic a- and b-wave amplitudes between iCre75;ndufs4loxP/loxP and control ndufs4loxP/loxP mice (ns for all stimulus intensities). Photoreceptor nuclei counts remained normal in iCre75;ndufs4loxP/loxP mice thorugh P180 (ns at 8 different retinal locations). In contrast, in Rpe65CreERT2;ndufs4loxP/loxP mice, only ~25% depletion of NDUFS4 was achieved within RPE-choroid complex 120 days after tamoxifen induction. Nevertheless, there was a trend toward reduced a- and b-wave amplitudes compared to control ndufs4loxP/loxP littermates (15-45% reductions over multiple stimulus intensities; p-values ranging from 0.07 to 0.16).

Conclusions : Rods are not dependent on intact complex I for normal light signaling and survival, supporting the prevailing concept that rods primarily rely on glycolysis. Although limited by suboptimal Cre recombination efficiency, the trend toward decreased ERG amplitudes in mice with RPE-specific deletion of ndufs4 may suggest that RPE oxidative metabolism is key in supporting photoreceptor light signaling.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×